• Hepatitis D Virus (HDV) RNA, Molecular Method
  • Cancer Antigen (CA) 19-9, Serum
  • Beta-2 Glycoprotein 1 Antibody, IgG
  • X-Linked Adrenoleukodystrophy (ABCD1) Gene Mutation Analysis, Tissue
  • Small Lymphocytic Lymphoma, FISH, Tissue
  • MSK-IMPACT™, Solid Organ Gene Cancer Panel
  • Trichomonas vaginalis, Molecular
  • Neurofibromatosis Type 1 (NF1) Gene Mutation Analysis
  • BDX-XL2, EarlyCDT®-Lung, Blood Test for Early Detection of Lung Cancer
  • Lysergic Acid Diethylamide, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Human Immunodeficiency Virus (HIV) Drug Resistance (GenoSure), NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Human Immunodeficiency Virus (HIV) Drug Resistance (GenoSure), NGS
Medical Test

Reference Ranges
Access to Human Immunodeficiency Virus (HIV) Drug Resistance (GenoSure), NGS is restricted.